Marketable Securities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||
| Marketable Securities [Abstract] | |||||||||||||||||||||||||||||||||||||
| Marketable Securities | 3. Marketable Securities
The Company acquired equity securities listed in Hong Kong Securities Exchange.
Included in non-operating income (expenses), net unrealized gain from marketable securities for the years ended March 31, 2024, 2025 and 2026 of $952, $3,163 and $1,931, respectively.
Net proceeds from sale of marketable securities for the years ended March 31, 2024, 2025 and 2026 were $, $5,647 and $12,727, respectively and realized gain from sales of marketable securities for the years ended March 31, 2024, 2025 and 2026 were $, $1,470 and $3,574, respectively. For the purposes of determining realized gains and losses, the cost of securities sold was determined based on the average cost method.
The marketable securities were classified as Level 1 of the hierarchy established under ASC No. 820 because the valuations were based on quoted prices for identical securities in active markets. |
||||||||||||||||||||||||||||||||||||